End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.92 CNY | -3.33% | -2.68% | +24.30% |
Apr. 29 | Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug | MT |
Apr. 29 | Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.30% | 2.92B | |
+33.13% | 709B | |
+30.77% | 595B | |
-2.23% | 367B | |
+20.23% | 334B | |
+4.95% | 289B | |
+14.23% | 239B | |
+9.03% | 211B | |
-3.44% | 203B | |
+8.57% | 171B |
- Stock Market
- Equities
- 002773 Stock
- News Chengdu Kanghong Pharmaceutical Group Co., Ltd
- Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug